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Abstract
Background: P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP1) are membrane transporter proteins
which function as efflux pumps at cell membranes and are considered to exert a protective function against the entry of
xenobiotics. While evidence for Pgp and MRP transporter activity is reported for olfactory tissue, their possible interaction
and participation in the olfactory response has not been investigated.
Principal Findings: Functional activity of putative MDR transporters was assessed by means of the fluorometric calcein
acetoxymethyl ester (calcein-AM) accumulation assay on acute rat and mouse olfactory tissue slices. Calcein-AM uptake was
measured as fluorescence intensity changes in the presence of Pgp or MRP specific inhibitors. Epifluorescence microscopy
measured time course analysis in the olfactory epithelium revealed significant inhibitor-dependent calcein uptake in the
presence of each of the selected inhibitors. Furthermore, intracellular calcein accumulation in olfactory receptor neurons
was also significantly increased in the presence of either one of the Pgp or MRP inhibitors. The presence of Pgp or MRP1
encoding genes in the olfactory mucosa of rat and mouse was confirmed by RT-PCR with appropriate pairs of species-
specific primers. Both transporters were expressed in both newborn and adult olfactory mucosa of both species. To assess a
possible involvement of MDR transporters in the olfactory response, we examined the electrophysiological response to
odorants in the presence of the selected MDR inhibitors by recording electroolfactograms (EOG). In both animal species,
MRPs inhibitors induced a marked reduction of the EOG magnitude, while Pgp inhibitors had only a minor or no measurable
effect.
Conclusions: The findings suggest that both Pgp and MRP transporters are functional in the olfactory mucosa and in
olfactory receptor neurons. Pgp and MRPs may be cellular constituents of olfactory receptor neurons and represent
potential mechanisms for modulation of the olfactory response.
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Introduction
Among the numerous protein transporter systems present in
many mucosal and epithelial tissue a few are toxically relevant
efflux transporter proteins. They belong to the superfamily of
binding cassette transporters (ABC transporters), transmembrane
ATP-driven export pumps, and include amongst others two
important members of two subfamilies, the P-glycoprotein (Pgp,
gene symbol ABCB1) and the multidrug-associated resistance
protein MRP1 (MRP1, gene symbol ABCC1). These proteins are
especially well-known for their role in mediating the phenotype of
multidrug resistance (MDR) seen in cancer cells where MDR is an
acquired resistance against multiple chemotherapeutic drugs [1,2].
Moreover these transporters are known to exert a protective role
against toxicity of endo-and xenobiotics [3].
Beyond its inauspicious role in cancer treatment, Pgp has an
important physiological function in normal tissue. In mammals,
Pgp is constitutively expressed in cells specialized in selective or
secretory transport, and generally in all tissues in which a highly
selective compartmentalization is needed, such as kidney, pancre-
as, adrenal, glands, colon, jejunum, liver, brain [4]. Pgp has also
been detected in tissues with barrier functions, such as in
endothelial cells of the blood-brain barrier [5]. MRP1 ubiquitously
distributed in tissue [6] is like Pgp an organic anion transporter
protein, albeit with a different substrate profile. Pgp being a
transporter with broad specificity [7] transports large hydrophobic
positively charged molecules out of the cell, while preferred
substrates of MRP1 are conjugated organic anionic compounds,
some peptides and neutral compounds conjugated to glutathione,
glucuronate or sulfate. Due to its ubiquitous presence in normal
cellular physiology, various physiological functions including tissue
defense against xenobiotic and endogenous toxic metabolites [8]
are proposed.
Peripheral sensory systems like olfaction and taste localized at
the interface between environment and body possess natural
physical cellular structures with barrier characteristics [9] but are
further endowed with a protective biochemical barrier. Detoxify-
ing enzymes are particularly important in epithelia exposed to
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36167xenobiotic chemicals. The nasal tissue, especially, at the entry
route to the CNS, has provided its different mucosal epithelia with
several xenobiotic metabolizing enzymes [10–12] transforming
xenobiotics into metabolites that are more readily absorbed.
Multidrug transporters like Pgp and MRP1 are also expressed in
nasal tissue, as well in respiratory and olfactory epithelia [10,12–
14]. The olfactory epithelium, segregated from the respiratory
epithelium, lines the dorsal part of the nasal cavity harboring the
olfactory receptor neurons (ORNs). Their specialized cilia are
confronted with external cues which are beneficial or detrimental
to the receiving organism. ORNs are first-order neurons,
surrounded by supporting or sustentacular cells forming the apical
layer of the olfactory mucosa. The underlying biochemical events
of odorant detection and signal transduction are now well
elucidated [15,16].
In olfactory epithelium (OE) of bovine and mouse [17,18]. Pgp
hasbeenlocalizedtotheapicalcelllayer,mostlikelytosustentacular
cells. Also a very robust immunolocalization of MRP1 to sustentac-
ular cells of the rat OE has recently been shown by Kudo et al. [19].
Further expression of MRP1, MRP3, MRP 4 and MRP 5 has been
reported in the olfactory epithelium of rat [14,19,20]. The few
functional MDR activity tests in OE of mammals have focused on
Pgp transport activity across excised olfactory tissue or whole
animals,andsofarnofunctionaltestforMRP1hasbeenperformed.
Transporter activity of Pgp and MRP has been shown in OE of
Xenopus tadpoles expressing the two transporter systems in susten-
tacular cells and olfactory neurons [21].
In the present study we assessed the function of the two
transporters Pgp and MRP1 involved in multidrug resistance in
the olfactory epithelium and compared two animal species. The
calcein-AM assay is one of the best choices to probe MDR
activities [22,23] and analysis of fluorochrome efflux in combina-
tion with pharmacological tools is the major indicator of their
expression and function. We confirmed MDR transporter
expression in the OE by reverse transcription–PCR analysis and
revealed constitutive expression of Pgp and MRP1 in newborn and
adult animals.
To investigate whether MDR transporters may be directly or
indirectly implicated in the olfactory response we conducted
electrophysiological analysis of odorant-evoked responses by
electroolfactogram recordings (EOGs) which measure mainly the
odorant induced generator potentials thus reflecting initial
stimulus-induced events from the periphery.
Materials and Methods
Animal treatments
All procedures involving animals were conducted in accordance
with a protocol approved by the Local Ethics Committee for
Research on Animals of the University of Bourgogne (France)
under the approval number B1910. The care and husbandry of
animals was in conformity with guidelines of the European
Communities Council directive of Nov, 1986, (86/609/EEC).
Adult Wistar rats and BALB/c mice of both sexes (2 to 7 months
old) were purchased from Janvier, Le Genest-Saint-Isle, France,
mouse and rat pups were provided by the local animal facility.
Adult animals were deeply anesthetized by carbon dioxide
inhalation, rat and mouse pups by hypothermia, and sacrified by
decapitation.
Calcein accumulation assay
A specific test for multidrug transporter-mediated activity is to
measure intracellular calcein accumulation in the presence or
absence of MDR inhibitors. Calcein acetoxymethlyl ester (calcein-
AM) is a lipophilic, nonfluorescent dye that diffuses into cells
where it is cleaved by cytosolic esterase to a green fluorescent dye.
The amount of transporter activity is therefore inversely propor-
tional to the accumulation of intracellular calcein fluorescence.
Imaging experiments with calcein-AM were performed with a
monochromator-based imaging system (Polychrome V, Till
Photonics, Graefelfing, Germany) attached to an upright micro-
scope (Olympus BX51WI) via a light guide and viewed with a x10
water immersion objective (UMPlanFl, NA 0.30). Fluorescent
images were acquired with an IMAGO QE cooled charge-coupled
device camera (PCO AG, Kelheim, Germany) controlled by the
TILLvisION 4.0 software (TILL Photonics). The excitation
wavelength for calcein was 480 nm and emitted light was collected
by an appropriate dichroic mirror. Coronal slices of 100 and
150 mm thickness were prepared from olfactory epithelium of
newborn mice and rats at postnatal day 0 to 2. Rapid hardening of
the nasal bones and cartilage prevented exact acute slicing in older
animals. Sections of the middle to dorsal portion of the nasal cavity
where the olfactory bulbs are just apparent were cut on a vibrating
slicer (Leica VT 1000 M/E, Nussloch, Germany) while submerged
in cold standard Ringer solution. Slices were stored at 4uCi n
Ringer until transfer to an immersion chamber for optical
recording at room temperature (RT).
A calcein accumulation experiment was performed in individual
but serially adjacent slices from one animal, yielding normally 2–4
slices. As one slice was incubated with calcein–AM alone serving
as control, thus allowing each experiment to have its own control,
the remaining ‘‘sister’’ slices were loaded each with calcein-AM
concomitantly one inhibitor. Calcein-AM concentration was in all
instances 1 mM.
Typically one to three of the different inhibitors were studied in
slices from one animal. A pre-incubation period of 8 min was
necessary before fluorescence recording could be started. There-
after images were recorded in a time series from 0 (t=0) to 60 min
(t=60) at fixed 15-min intervals over 60 minutes of experiment.
Calcein accumulation was measured as averaged pixel intensity
inside of regions of interest (ROIs) for each time point in the
60 min sequence. For evaluation at the tissue level ROIs were
delineated over an area extending over the entire height of the
olfactory epithelium. Areas of different size and shapes or position
gave essentially the same information and in each ROI no
distinction was made between populated or non-populated pixel
areas. Rates of change over time were calculated from slopes by
linear regression. In addition, fluorescence intensities at the
intracellular level of single cells were evaluated from fluorescence
images (snapshot) at the 60 min end-point where small ROIs (8–
12) were placed over the cell bodies of single cells. Ratios of
inhibitor-to-control fluorescence intensities were than calculated
from corresponding end-point images of the same series.
Background fluorescence was subtracted in all recordings and
determined using ROIs of identical shape and size as for
evaluation, but placed in a cell-free area of the image.
Electroolfactograms
We recorded electroolfactograms (EOGs) in the submerged field
potential recording technique adapted from [24] with some
modification. The severed head was cut in the mid-sagittal plane
to expose the nasal septum in its totality, or after its careful
excision the underlying endoturbinates. We recorded either from
matched locations on the septum in rat and mouse, and
additionally from a location in turbinate IIb of rat. Recordings
were done by means of an Ag/AgCl wire in a disposable plastic gel
loader tip filled with conductive gel (WPI, UK) and an Ag/AgCl
disc positioned under the head serving as reference electrode. Both
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were low pass filtered, sampled at 100 Hz, and digitized via a data-
acquisition board (National Instruments, France) run by custom-
made software on a personal computer. Data were later analyzed
using Clampfit 8 (Axon Instruments, DIPSI, France) and other
commercial software. The olfactory region was continuously
superfused with a thin film of standard Ringer solution fed by
gravity at a flow rate of 9 mL/min. Test stimuli were applied via a
valve-operated loop (Rheodyne, Bioblock, France) with a volume
of 120 mL allowing direct switching to the desired test solution.
Solutions and chemical stimuli
The standard Ringer consisted of (in mM) 140 NaCl, 5 KCl, 2
CaCl2, 2 MgCl2, 10 HEPES adjusted to pH 7.2–7.3 and to 310
mosm with glucose. Ringer containing the appropriate concen-
tration of transporter inhibitor are referred to as inhibitor-Ringer.
MDR transporter inhibitors used were verapamil, cyclosporin A,
probenecid, and MK571, prepared as 1 M stock solutions in
Ringer except for probenecid which was dissolved in a diluted
solution of NaOH buffered to pH 7.3 and prepared on the day of
the experiment. Cyclosporin A was prepared as 25 mM stock
solution. The following odorant and test stimuli were used: isoamyl
acetate and 2,5-dimethyl pyrazine as single/pure odorants, and a
mixture composed of isoamyl acetate, benzaldehyde, 2-heptanone,
octanal, 1-octanol, acetophenone, octanoic acid, and 1,8-cineole.
Odorants were prepared as 1 M stock solutions, 3-isobutyl-1-
methyl-xanthine, (IBMX) and the mixture as 10
21 M stock
solutions in dimethylsulfoxide (DMSO), elevated K
+solution was
the same as Ringer except that NaCl was replaced by 140 mM
KCl. Final dilution in Ringer or inhibitor-Ringer to the desired
concentration was freshly made before each experiment. Stimuli
were diluted either in Ringer or inhibitor-Ringer. Test stimuli
concentrations are reported as ‘loop’ concentration and not
corrected for further dilution in the bath. Final DMSO
concentration was maximally 0.01% or less with exception of
the IBMX solution containing 0.1%, giving rise to a small EOG
contributing to 3–5% of the maximal IBMX-induced EOG
amplitude. Calcein-AM was prepared as 1M stock solution in
DMSO and diluted to a final concentration of 1 mM in standard
or inhibitor-Ringer at the start of the experiment. All experiments
were performed at room temperature (20u–22uC).
Olfactory modulation experiments
Modulation experiments involved the acquisition of three
successive series of EOG recordings evoked by a standard
stimulation protocol consisting of a set of stimuli sequentially
presented to the olfactory mucosa. We acquired (1) an initial
control series of EOGs in standard Ringer solution, (2) after having
switched to inhibitor-Ringer for 10 min, a second series of EOGs
in the presence of the desired inhibitor and stimuli prepared in
inhibitor Ringer, (3) a third series of EOGs in standard Ringer was
started after a 20 min period of washout with standard Ringer.
This procedure was used for all inhibitor experiments, except that
MK571-containing Ringer was superfused for only 3 min. The
stimulus protocol consisted of sequentially applying KCl, IBMX,
the odorant mixture, isoamyl acetate and 2, 5-dimethyl pyrazine.
With the exception of KCl, the stimuli were presented at a
concentration of 10
25 and 10
24 M. Inter-stimulus interval was at
least 2 minutes. Peak amplitude of the EOG response was
measured as the maximum negative voltage deflection from
baseline. For comparison of response kinetics EOG waveforms
were normalized to their peak amplitudes. EOG rise times were
defined as the time of the start to the peak of the response. For
comparison the rates of rise were fitted to a sigmoidal function and
the half-maximal activation (V50) of treated and control EOGs
compared by a paired t-test. For comparison of decay time
waveforms were aligned on the peak of the amplitude and
inspected for disparities.
RT-PCR on olfactory epithelium
Tissue samples of liver and main olfactory epithelium of adult
(n=2) and neonate (n=2) animals of each species were rapidly
removed into PCR tubes, snap frozen in liquid nitrogen and stored
at280uC until RNA extraction. To avoid contamination with
respiratory cells only the caudal/ posterior one third of the
olfactory mucosa of the septum was peeled off from the cartilage
thereby avoiding also the area near the choanae (herein after
referred to as simply olfactory mucosa). Total RNA was extracted
from frozen tissue using RNeasy
TM Plus mini Kit (Qiagen, France)
according to the manufacturer’s instructions. The quantity and
purity of RNA was determined with a spectrophotometer
(Nanodrop 2000 Thermo Scientific). 1.3 mg RNA was reverse
transcribed using Superscript III First strand Synthesis System for
RT-PCR (Invitrogen) and oligo dT primers in a UNO II
Thermocycler (Biometra). PCR reaction was performed using
standard protocols with TaqPCR Master Mix (Qiagen, France).
PCR amplification was started with an initial denaturation in one
cycle at 98uC for 60 s, followed by denaturation step of 98uC for
30 s, annealing at 60uC for 40 s, and extension at 72uC for 60 s,
for a total of 35 cycles, followed by a final extension step at 72uC
for 5 min. Negative controls for contamination by extraneous
DNA (omission of reverse transcriptase) and RNA were run with
each set of reactions. Positive controls were done by amplification
of a cDNA fragment of cyclophilin A, a housekeeping gene.
Amplified cDNAs were separated by electrophoresis in a 1.3%
ethidium bromide stained agarose gel and visualized under UV
light on a Molecular Imager Gel Doc XR System (Bio-Rad). The
specificity of the PCR product was confirmed by sequencing.
Specific primers were designed by Blast searching using publicly
available sequence information of the GenBank of the National
Center for Biotechnology Information (http://www.ncbi.nlm.nih.
gov/BLAST/) and purchased from Operon (Eurofins MWG
Operon, Germany).
Data analysis
All figures giving qualitative information represent typical
results of at least three different experiments (stated when less).
Statistical analyses were performed using a two-tailed paired ratio
t-test [25] or one-sample t-test where appropriate. In both cases
differences were considered significant at p,0.05. Linear regres-
sion analysis was carried out to analyze calcein uptake rates and
linear relationships with R
2 values greater than 0.95 were used. To
detect far outliers Grubbs test was applied. All data analyses were
carried out with GraphPad 4.0. Data are expressed as mean 6
standard deviation (SD).
Chemicals
Calcein-AM was purchased from Invitrogene (France), IBMX
from Calbiochem (France), Verapamil and MK571 from Biomol
(France), all other chemicals were obtained from Sigma Aldrich
(St. Quentin, France).
Results
Functional testing of multidrug resistance transporter
activity
A specific test for multidrug-transporter mediated activity
(MDR) is to measure intracellular calcein accumulation in the
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the use of lipophilic acetoxymethyl ester of calcein (calcein-AM),
which crosses membranes. Once internalized and enzymatically
converted to calcein, the dye becomes highly fluorescent. Both
calcein-AM and calcein have been shown to be substrates for
MRP, but only calcein-AM is a substrate for Pgp [23]. To examine
the functional activity of MDR transporters we incubated olfactory
tissue slices of newborn mice and rats with calcein-AM in the
presence or absence of appropriate MDR inhibitors. Fluorescence
data were obtained from 28 slices from mice (n=16) and 30 slices
from rats (n=19).
Calcein-AM application led to an immediate but faint
fluorescence rise in olfactory tissue slices, and was barely
detectable during the first 8 minutes, not revealing morphological
structures of the tissue. This made it difficult to report the increase
in fluorescence during this time of incubation considered as pre-
incubation. Thereafter, the time series experiment was started at
time 0 and images sequentially acquired at fixed intervals of 15
min for a period of 60 min. Figure 1 B illustrates a representative
fluorescence distribution pattern in a part of a coronal section
through the mid-septal portion of the OE after incubation in 1 mM
calcein-AM for a period of 30 min. Calcein fluorescence
distribution was non-homogenous within the slice and developed
primarly within the olfactory epithelium layer as indicated in the
corresponding transmission micrograph (Figure 1A) showing the
general morphological aspects of the same section with its three
distinct main layers. The outer and upper layer represents the
olfactory epithelium (OE), the subjacent layer, the lamina propria
(LP), consists of connective tissue with nasal glands, blood vessels,
and olfactory nerve/axon bundles (fila olfactoria, FO) which also
accumulate calcein. These two layers overlay the nasal cartilag-
inous bone (CS) with its chondrocytes where a faint and patchy
staining of calcein fluorescence was also observed. Generally
similar patterns of fluorescence distribution for calcein appeared in
mouse and rat slices. Calcein uptake was estimated from intensity
changes in calcein fluorescence and evaluated in regions of interest
(ROIs) from all five time points. Figure 1C shows the fluorometric
time course of calcein accumulation over the 60 min experimental
period into the OE of mice and rats in absence of MDR inhibitors.
Fluorescence rose steadily and increased quasi linearly without
saturation over the time of experiment. Average calcein fluores-
cence levels in the OE were similar in magnitude in both species
but there was considerable variation in fluorescence uptake among
individual specimens. Uptake rates calculated from slopes by linear
regression ranged from 3.04–15.61 in rats and from 3.86–16.17 in
mice (arbitrary units/time, a.u./60 min).
Next we evaluated the effect of various inhibitors of MDR
transporters on calcein accumulation. The following four agents
well recognized for their MDR reversing or inhibiting capacities
were tested: verapamil and cyclosporin A are inhibitors of the Pgp
transporter, while probenecid and MK571 are inhibitors of MRP-
transporters. Direct observation by fluorescence microscopy
revealed that inhibitor-incubated tissue slices always exhibited
stronger fluorescence emission than when incubated with calcein-
AM alone. This is illustrated in the example in Figure 2A for
images of the 0, 30 and 60 min time points from mouse olfactory
slices incubated with calcein-AM or concomitantly with MK571.
When compared to the control with calcein, fluorescent visuali-
zation of the MK-treated slice demonstrated a progressively
increasing change in brightness already at the starting time point 0
(after 8 min of pre-incubation). Brightness was pronounced at the
30 min time point, and at the 60 min time point fluorescence
intensities in the MK–treated mouse slice covered the full range of
the 4065 intensity levels approaching partially sub-saturation to
slight saturation levels in a small band in the center of the OE.
Saturation occurred under the given recording conditions in all
mouse slices (4/4), but not in rat slices (0/4).
A more quantitative evaluation of calcein fluorescence changes
was carried out from regions of interest (ROIs) over the whole
height of the OE. The time-dependent fluorescence changes (of
non-saturation levels) of the above experiment showed an almost
linear increase over the 60 min period (Figure 2B) with a mean
fluorescence intensity of 575 a.u. for the calcein control and 2000
a.u. for the MK-treated slice at the 60 min time point, a value that
is 3.3-fold of that of the control value. The uptake rate, as
calculated from slopes, was 28.07 for MK and 7.5 for calcein
which represents approximately a4-fold increase. All of the four
inhibitors tested increased calcein fluorescence in mice OE, but
with different efficiencies. Figure 3 compares and summarizes the
effect of inhibitors on the rates of calcein accumulation in mouse
and rat slices. The increase was concentration dependant and the
effect was statistically significant at the highest concentration
tested, for verapamil at 200 mM, cyclosporin 10 mM, and
probenecid at 5 mM. Figure 3A also shows that increasing the
concentration of MK from 25 to 50 mM in mouse slices did not
further increase fluorescence intensities. In rat slices, all inhibitors
tested had a clearly visible fluorescence effect, but calcein
accumulation during inhibitor application was in general less
than in mouse slices (Figure 3B). MK was significantly effective at
both concentrations of 25 and 50 mM and cyclosporin at 10 mM.
Probenecid was significantly effective only at 2.5 mM. In both
species transporter inhibition by MK induced the highest uptake
rate, followed by cyclosporin. The experiments described above
demonstrated a significant effect on calcein accumulation by Pgp
and MRP-dependent inhibitors and the results suggest the
presence of at least two functional MDR transporters in the OE.
Because the whole surface of the OE was incubated and
exposed to calcein-AM, the above method measured the tissue
response from a heterogeneous cell population in the OE and did
not distinguish individual cell types. The OE consists of at least
three different cell types organized in horizontal layers, but due to
a general lack of contrast of the conventional fluorescence image it
was not possible to reveal the exact tissue and layer boundaries.
The small narrow band in the center of the OE, however, could be
identified as the layer populated by the cell bodies of olfactory
receptor neurons (ORNs). Within this layer details on cell
morphology and dendritic knob-bearing structures became best
detectable by the end of the experiment at the 60 min time point
as shown in Figure 4A. This made it possible to evaluate inhibitor-
dependent calcein accumulation in single ORNs (Figure 4B) from
end-point images of before described recordings. We calculated
ratios of intracellular fluorescence accumulation in single ORNs in
the absence and presence of the four tested inhibitors. MK had the
largest inhibitory effect and significantly increased calcein in mice
ORNs about 3-to 4fold and 2-to 3-fold in rats (Figure 4C). In mice
ORNs, probenecid at 5 mM, and cyclosporin at both tested
concentrations was also effective. In rats, probenecid was only
significantly effective at a concentration of 2.5 mM, cyclosporin
and verapamil at the highest concentration tested. In some
instances we were also able to evaluate the fluorescence changes at
the 60 min end-point for a small number of sustentacular cells.
Cells were selected on morphological criteria and evaluated for
fluorescence changes in presence of 10 mM cylosporin or 50 mM
MK571. As for ORNs, MK appears to have the largest inhibitory
effect increasing fluorescence about 2.5-fold in mouse and 3.4-fold
in rat sustentacular cells while fluorescence increase with
cyclosporin was 2-fold for mouse and rat (not shown).
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To further corroborate the results of the functional activity of
multidrug transporters, RT-PCR was undertaken to confirm
whether the encoding gene for drug-efflux conferring multidrug
resistance transporters P-glycoprotein (Pgp) and multidrug resis-
tance-associated protein (MRP) were expressed in olfactory
mucosa. We tested for mRNAs of the two P-glycoprotein isoforms,
Mdr1a and Mdr1b, and Mrp1 in olfactory mucosa and liver tissue
in newborn and adult rats and mice. To ensure olfactory tissue
purity we took great care to avoid respiratory epithelium
contamination in our samples. Specific primer pairs for the
detection of the mouse and rat mdr1a, mdr1b and mrp1 cDNAs
(Table 1) were used. These primers were designed to amplify
cDNA from mRNA and not genomic DNA sequences. Agarose
gel separation of the amplification products showed cDNA
fragments of the expected size (Table 1) for all three transcripts.
All samples of rat and mouse tissue tested expressed mdr1a, mdr1b
and mrp1 (Figure 5 A, B). Cyclophilin A was used as a positive RT-
PCR control (c in Figure 5 A, B). As expected, no bands were
detected in the negative control, which consisted of replacing
cDNA templates with water (in Figure 5 A, B). PCR products were
sequenced to confirm identity of the amplicons. The analysis
revealed the presence of mRNA for both isoforms of P-
glycoprotein, Mdr1a and Mdr1 b, and Mrp1 which indicates that
the genes are very likely expressed in olfactory mucosa and liver of
newborn and adult animals. This expression pattern persisted
throughout the developmental period into adulthood.
Modulation of the olfactory response
To test the hypothesis that MDR activities may be involved in
the peripheral processing of odorants we directly assessed the
function of the olfactory neurons by recording stimuli evoked
electroolfactograms (EOGs) in the absence and the presence of
MDR inhibitors. We sampled EOG responses from two olfactory
mucosal surfaces, the septum (n=18) and the turbinate (n=18) in
rat, and from a matching recording site in the mouse septum
(n=20). A series of chemical and odorant stimuli were presented,
consisting of KCl, IBMX, an odorant mixture, and two different
pure odorants, isoamyl acetate and 2,5-dimethyl pyrazine. IBMX
is a phosphodiesterase inhibitor thus increasing cAMP which leads
in turn to cyclic nucleotide channel (CNG) activation. KCl
activates voltage-dependent channels i.e. Na
+ and Ca
2+ and is a
measure of the general excitability of the preparation.
Representative control EOG traces evoked by the series of
stimuli at a concentration of 10
24 M recorded in the septum of rat
and mouse, respectively, are represented in Figure 6A. Qualitative
similar recordings were also obtained from the recording site in the
turbinate of the rat. As expected EOG waveforms varied with
stimuli, as well as with animals and the recording location. All
responses were characterized by monophasic negative waveforms
with a rapid rise to peak and a slower return to baseline or near to
the baseline. With the exception of KCl, all stimuli were tested at
two increasing concentrations, at 10
25 and 10
24 M. Response
magnitude was concentration-dependent (not shown) and the
relation between the peak amplitude of the two concentrations
varied between 1.8 and 3.2-fold depending on the substance.
Odorant responses were largest in the septum of the rat. Mean
peak amplitude evoked by the mixture at a concentration of 10
24
M was 3.9260.85 mV ranging from 2.55–5.46 mV, while isoamyl
acetate at the same concentration produced a mean amplitude of
1.2860.56 mV ranging from 0.61 to 2.73 mV. Compared to rats,
all stimuli induced-response magnitudes in mice were generally,
approximately between 64–72 % smaller (Figure 6A), i.e. the
mixture-evoked mean peak amplitude for the concentration of
10
24 M was 1.1860.36 mV ranging from 0.52–1.77 mV. For the
modulation experiments the four different previously tested
inhibitors were applied at the following concentrations, verapamil
at 200 mM, cyclosporin at 5 mM, probenecid at 2.5 mM, and MK
at 25 mM, additionally cyclosporin was tested at a concentration of
10 mM, and probenecid at 5 mM in mice. Figure 6B illustrates the
effects of the four different inhibitors on the mixture-evoked
response in the rat septum. In these recordings verapamil,
probenecid and MK reduced the peak amplitude to between
40–52%, while cyclosporin had no measurable effect. Similar
reductions of amplitude but with varying degree of inhibitions
were observed with all other stimuli, also in rat turbinates and
mouse septum. The effects were reversible after initial reduction as
peak amplitudes were restored to 50–100 % after washout of the
inhibitor.
Because the absolute magnitude of a response to a stimulus
varied between different preparations and specimens, the ampli-
tude of each stimulus was normalized to its control response before
inhibitor application. The averaged normalized amplitudes in the
Figure 1. Calcein fluorescence pattern and accumulation in olfactory tissue slices of mouse and rat. A: Transmission light micrograph of
a part of a typical coronal section through the main olfactory epithelium of mouse featuring three main layers: the olfactory epithelium (OE), the
lamina propria (LP) and the nasal cartilage of the septum (CS). B: Pseudocolored fluorescence image of the same section after 30 minutes of
incubation with 1 mM calcein-AM. Note that main staining occurred in the OE, some staining in the LP mainly in the fila olfactoria (FO), and cartilage
cells, the chondrocytes (arrowhead). C: Time-dependent changes of calcein accumulation in the OE of rats (n=19) and mice (n=16) as determined
from average fluorescence intensities of regions of interests (ROIs) at indicated time points. Fluorescence intensity in arbitrary units (a.u), scale bar in
A=50mm.
doi:10.1371/journal.pone.0036167.g001
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Figure 7. In general KCl responses were less sensitive to all tested
inhibitors independent of the recording site. Verapamil (200 mM)
had a moderate decreasing effect on all responses in rat and mice,
but this was not consistently significant, only for isomayl acetate
and 2,5-dimethyl pyrazine in the rat septum and turbinate. In the
mouse septum only the response to the mixture and 2,5-dimethyl
pyrazine was significantly decreased. The presence of 5 mM
cyclosporin decreased slightly the response amplitudes in all three
recording sites, but the effect was not significant. Increasing its
concentration to 10 mM (n=2) remained also without significant
effect. Of the four compounds tested, the MRP specific inhibitors
MK571 and probenecid introduced the strongest reduction. The
responses to all stimuli in all three recording sites were
dramatically and significantly reduced by MK (52–94 %) at a
concentration of 25 mM. Probenecid at 2.5 mM caused similar
significant reductions in all responses in rat but was less effective in
Figure 2. Calcein fluorescence in olfactory slices is elevated in
the presence of an MDR inhibitor. A: Time series images in
pseudocolor of two individual mouse olfactory slices incubated with
1 mM calcein–AM (left panel), or concomitantly with 25 mM MK571
(right panel). The numbered images correspond to individual frames at
indicated time points. Some pixel saturation occurred at the 60 min
time point in the center portion of the OE in MK-treated slice. The two
slices are from the same specimen, recorded with identical exposure
times. B: Time-dependent accumulation of fluorescence intensity
(arbitrary units, a.u) for calcein in the absence or presence of 25 mM
MK571 as evaluated from regions of interest (ROIs), saturated pixels
were not considered for evaluation. Data derived from above
experiment. Values of the pseudocolor code bar scales from 0 (low,
blue) to 4095 (high, red), scale bar in A=200 mm.
doi:10.1371/journal.pone.0036167.g002
Figure 3. Effect of various MDR inhibitors on calcein accumu-
lation in olfactory slices of rat and mouse. Olfactory tissue slices
were incubated with 1 mM calcein-AM in the absence or presence of the
specific MDR inhibitors. Bars represent average accumulation rates as
determined from slopes over all time points of the experiment, in (A)
from mice, and in (B) from rats. The following inhibitors were tested:
vera = verapamil at 100 and 200 mM, CsA = cyclosporin A at 5 and
10 mM, prob = probenecid at 2.5 and 5 mM, and MK = MK571 at 25
and 50 mM. Values from at least three independent assays for each
inhibitor and concentration. * p,0.05.
doi:10.1371/journal.pone.0036167.g003
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2.5 mM probenecid in mouse EOG responses, 5 mM were
required for a reduction of 85 to 95% for all stimuli-induced
responses.
To uncover disparities in the shape of EOG waveforms, we
normalized all recordings to their peak amplitudes, superimposed
and aligned them on their onset. A representative sample is shown
in Figure 8 for the effect of the four tested MDR-inhibitors on the
averaged mixture-induced responses in the rat septum. Inspection
of the superposition of all 108 pairs (9 pairs/ inhibitor/ recording
site, n=4) did not reveal any distortion of the general aspect of the
waveform, but subtle differences in activation kinetic. In approx-
imately 65% (61/93) of the inhibitor-control pairs the time course
of the rising phase was nearly identical and did overlap to almost
100 %, the remaining 35 % showed a shift to slower rise times. We
further analyzed the rates of rise by fitting the normalized
responses to a sigmoidal curve (not shown) and measured the half-
maximal activation (V50). Although the shift to slower rise times
was present in all of these recordings, it was statistically not
significant. To compare decay kinetics waveforms of inhibitor-
control pairs were aligned on their peak amplitude and the
overlays inspected for differences. Decay kinetics were not
systemically affected. In 40/90 waveform pairs no change
occurred, while 35/90 had slightly slower and 15/90 faster decay
kinetics, although there was a tendency for verapamil and
probenecid to show faster decay kinetics on the rat septum. This
was independent of stimuli or inhibitor used. Though the peak
amplitudes of the voltage responses were different, the overall
shape of the waveform was only modestly changed or stayed
comparable to that of the control.
Discussion
The results of our study demonstrate MDR transporter activities
in the olfactory epithelium and provide comparative data on the
function of Ppg and MRP transporters for two animal species, the
mouse and the rat. Using a fluorometric assay in combination with
pharmacological inhibitors we show that both transporters are
functional in the olfactory epithelium, and moreover in olfactory
neurons. Electrophysiological recordings from the OE indicated
that the response to odorants was reduced when MDR activity was
inhibited thus revealing their activity.
Functional assays to detect MDR transporter activity involve
the use of fluorescent transporter substrates such as calcein-AM
[26,27]. While typically the fluorescent assay is used for detection
of MDR transporters in MDR overexpressing cells, the assay has
already been proven to be suitable in physiological acute slice
preparations of rodent taste cells and Xenopus olfactory epithelium
[21,28]. The assay is based on the principle that active MDR
Figure 4. MDR inhibitors enhanced calcein accumulation in
olfactory receptor neurons (ORNs) of mouse and rat. A:
Pseudocolored fluorescence micrograph of a part of an olfactory slice
from rat in the presence of MK571 (50 mM) at the 60 min time point.
Arrowheads point to ORNs appearing as pear-shaped cells with visible
knob-bearing dendritic structures. Fluorescence image adjusted for
contrast, pseudocolor bar scales from low (blue) to high (red)
intensities. LP = lamina propria, scale bar in A=20 mm. B: Fluorescence
scaling is different for the two images, the value of the pseudocolor bar
scales 0 to 1500 for the left panel and micrograph of a single mouse
ORN in the presence of calcein-AM (left panel) and a row of ORNs in the
presence of cyclosporin A (right panel). Both images are taken at the
60 min time point. Note, that the 0 to 4095 for the right panel. Scale bar
in the left panel=5 mm, and 10 mm in the right panel. C: Intracellular
inhibitor-dependent increase in fluorescence intensities was evaluated
from regions of interest (ROIs) placed over the cell bodies of ORNs at
the 60 min time point. Bars represent the averaged inhibitor-to-control
ratios of calcein fluorescence intensities in mouse (upper panel) and rat
(lower panel) for four tested inhibitors: vera = verapamil at 100 and
200 mM, CsA = cyclosporin A at 5 and 10 mM, prob = probenecid at 2.5
and 5 mM, and MK = MK571 at 25 and 50 mM. * p,0.05.
doi:10.1371/journal.pone.0036167.g004
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Rat
Gene Primer (59-39)
Genbank Accession
No Amplicon (bp)
MRP1 (Abcc1) forward ATGTGACTCTCAAGGGCTCCGTGG NM_022281 691
reverse GTGCTGCTGTGCTGCTGGTTAGTA
MDR1a (Abcb1a) forward GAGTGAAAAGGTCGTCCAGGAAGCG NM_133401 234
reverse TCTCGCATGGTCACAGTTCATGAGC
MDR1b (Abcb1b) forward CCCAAAGTGACACTGGTGCCTCTG NM_012623 564
reverse GCCTGGAGCCCATAGCCCCTTTA
Cyclophilin A (CypA) forward TGGCACTGGTGGCAAGTCCA NM_017101 229
reverse TGGACCCAAAACGCTCCATGGC
Mouse
Gene Primer (59-39)
Genbank Accession
No Amplicon (bp)
MRP1 (Abcc1) forward AGCATTGTGCAGGCCAGCGT NM_008576.3 822
reverse CTCCGAGGCCAGGTCCTGCT
MDR1a (Abcb1a) forward CCTGAAACCCAGCGGCAGAACA NM_011076.3 265
reverse GCCTAGACCCTGTAGCCCCTTTCAC
MDR1b (Abcb1b) forward GTGTCCACAGAAAGCAAGACCAAGA NM_011075.3 482
reverse GGCGCCCATCGCCCCTTTAA
Cyclophilin A (CypA) forward CATCCTAAAGCATACAGGT NM_008907 165
reverse TCCATGGCTTCCACAATGTT
doi:10.1371/journal.pone.0036167.t001
Figure 5. Distribution of mdr and mrp mRNAs in rat and mouse olfactory and liver tissue. The presence of mdr1a, mdr1b and mrp1 mRNA
analyzed by means of RT-PCR from samples of olfactory mucosa and liver tissue. Electrophoresis of PCR products A: from newborn and adult rat, B:
from newborn and adult mouse. The cDNAs were amplified with rat- and mouse-specific primers for the Mdr1a, Mdr1b and Mrp1 genes. All tissues
were positive for the tested cDNAs (note that staining in A, lane 12 for mdr1b is weak, but visible on the gel). c = cyclophilin A used as positive
control, w = negative control containing water in place of cDNA, m=DNA size markers. All gels were run together except for the newborn rat, which
was run on a separate gel. Results from a single experiment.
doi:10.1371/journal.pone.0036167.g005
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they reside resulting in low fluorescence. This activity can be
reversed in the presence of specific inhibitors thus enhancing
fluorescence intensity. Our functional studies show that calcein
accumulation in rodent OE is significantly enhanced in the
presence of potent Pgp and MRP inhibitors. To increase the
probability of detecting transporter activity, two pairs of structur-
ally diverse inhibitors were selected appropriate to the transporter
type. The calcein fluorescence readily developing in the OE in the
absence of any of the selected inhibitors argued, in a first instance,
against a functional expression of MDR transporters in the OE.
But all four selected inhibitors, however, significantly increased
calcein fluorescence in the OE in a time- and concentration-
dependant manner, thereby revealing similar inhibitor profiles for
both animal species with small differences in sensitivity among
them with probenecid being already saturated at the lower
concentration. To make appropriate interpretation of inhibitor
interaction data the specificity of the inhibitors has to be
considered. The Pgp inhibitors cyclosporin and verapamil have
been proven to be reversing agents in ‘physiological’ sensory cells
[21,28] and in cells transiently transfected with Pgp [7]. In a large
in vitro study on recommendation for inhibitor/probe use,
cyclosporin and verapamil have been classified as good Pgp
inhibitors [29]. Considering that verapamil is a known calcium
channel blocker, it may or may not exert this function in the
calcein-AM assay as calcein fluorescence is insensitive to changes
in cytosolic calcium [30]. MK571 has been previously defined as a
specific blocker of MRP1 [31] but also inhibits other MRP species.
Probenecid is an inhibitor of organic anion transporters acting on
MRP isoforms other than MRP1, but not on Pgp [32]. Other
members of the MRP family as MRP4 are expressed [14] and
MRP3 and MRP5 has been recently histochemically localized in
rat olfactory receptor neurons [33]. MRP5 activity cannot be
assessed with the assay used here as calcein is not a substrate [34],
but we cannot exclude that MRP3 or MRP4 activity may
contribute to calcein accumulation in our experiment. Assuming a
high specificity of the selected inhibitors the increased calcein
accumulation/retention is brought about by the activity of Pgp
and MRP1 and/or MRP-like transporters. Both transporters,
functional in the OE of newborn rodents, behaved in a similar
manner in each species.
The most striking result of the present study was the modulation
of MDR activity in single ORNs. Microscopical examination at
the 60 min time point allowed to unambiguously identifying
ORNs by their distinctive and unmistakable morphology in
contrast to the more undescriptive sustentacular cells. Calcein
uptake curves for all inhibitors tested were nearly linear over
60 min of experiments thus allowing for evaluation of calcein
accumulation at the 60 min end-point. Cellular accumulation of
calcein by Pgp or MRP inhibition was associated with an
inhibitor-induced increase in fluorescence within single ORNs
and comparison between single ORN and tissue fluorescence
intensities revealed qualitative similarities in inhibitor profile.
These findings suggest a functional activity of the two transporter
systems in single rodent ORNs. Very similar results have been
obtained for larval Xenopus ORNs [21]. Further support to our
findings comes from immunolocalization and antisense signaling
of MRP1 [14,19] both reporting the presence of MRP1 mRNA in
ORNs of adult rat. More intriguing is the finding that MRP1 is
most likely expressed in olfactory cilia of rats [35], the site where
initial olfactory transduction takes place. In contrast to the
presence of MRP1, no Pgp immunological expression is reported
for rat olfactory mucosa. In a recent immunohistological study
Thiebaud et al. [33] localized Ppg expression only to a vessel in
the submucosa. The discrepancy may be explained by the method
as the calcein–AM staining method is more sensitive than
immunostaining. Then again, evidence based on an immunohis-
tochemistry with the antibody C219, as used by [33] is very often
compromised in paraffin and/or formalin treated tissue [36,37].
For immunolocalization of Pgp often various fixation conditions
and different antibodies are required as shown for rat taste buds or
hippocampus neurons of rat [28,38].
Reports on localization or activity of MDR transporters in
normal physiological neurons are yet scarce. Normally present in
transport epithelia these MDR transporters are almost considered
Figure 6. Modulatory effect of MDR inhibitors on the olfactory
response to odorants in rat and mouse. A: Representative
superimposed electroolfactogram traces recorded in the septal
olfactory mucosa of a rat (left) and a mouse (right) under control
conditions. Responses are recorded to a sequence of stimuli (inset, left)
as KCl, IBMX, a mixture of odorants, isoamyl acetate and 2,5-dimethyl
pyrazine, at concentrations of 10
24 M. B: Representative selection of
EOG recordings from rats in response to the mixture at a concentration
of 10
24 M before (control, solid line), during (inhibitor, dashed line), and
after (recovery, dot-dash line) application of four MDR inhibitors:
verapamil at 200 mM, cyclosporin A (CsA) at 5 mM, probenecid at
2.5 mM and MK571 at 25 mM. Recordings are from four different
specimen.
doi:10.1371/journal.pone.0036167.g006
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RT-PCR analysis of rat brains revealed the neuronal expression of
MRP1, MRP3, MRP4 and MRP5 [39,40]. Pgp also has been
localized to a specific neuronal cell type in the hippocampus of
mice [41]. More interestingly, both genes, mdr1a and b, were
transiently overexpressed in hippocampus neurons after a path-
ological situation with insult [42] pointing to a role of Pgp in
neuroprotection.
Immunofluorescence labeling localized MRP1 to the sustentac-
ular cell layer of the rat OE [19] and it would have been of special
interest to assess MDR functionality in the whole sustentacular
cellular layer. This band is only 6–9 mm small and the
sustentacular cells are less contoured than ORNs. As they are
intermingled with the ORNs, we have rarely been able to identify
them unambiguously but for cyclosporin and MK end-point
fluorescence intensities. The sustentacular cells show comparable
fluorescence intensities to ORNs, and MK appears to have the
largest inhibitory effect. This suggests that both cell types, ORNs
and sustentacular cells, contributed to the overall fluorescence in
the OE measured in presence of Pgp or MRP inhibitors.
To obtain evidence that the functionally detected transporters
are expressed in OE, RT–PCR analysis was performed. Recent
studies have detected the presence of mRNA of MRP1, MRP3,
MRP4, and MRP5 in adult rat OE [14,19,20,33], but no data are
avaible for the OE of mouse or newborn rodents. Our RT-PCR
results show that both Pgp encoding genes mdr1a and mdr1b as well
MRP1 are expressed in OE of newborn and adult animals of both
species. Despite of differences in the tissue source, this is in
agreement with previous results for adult rat OE reported by other
authors [14,19,20]. The aforementioned investigations included
olfactory endoturbinates or used endoturbinates exclusively [20]
(personal communication) as olfactory tissue source. As turbinates
contain significant amounts of contaminating respiratory cells [43]
we exclusively sampled olfactory tissue to perform RT-PCR. Thus
the presented results on mdr1a, mdr1b and MRP1 expression are
olfactory tissue-specific for newborn and adult rat and mouse. The
perinatal expression pattern of Pgp isoforms and MRP1 does not
undergo changes with postnatal maturation as we find all three
MDR transporters expressed in adult animals of both species. We
do not know, however, if the level of expression is increased during
Figure 7. Summary of the modulatory effects of four MDR inhibitors on olfactory response amplitudes. A: in the rat olfactory septum,
B: in the rat turbinate, and C: in the mouse olfactory septum. Bars represent normalized average peak amplitudes. Responses were normalized with
respect to control before inhibitor application which was set to unity. The following stimuli were sequentially applied in control condition and in
presence of the specified inhibitor: KCl, IBMX, a mixture of odorants (MIX), isoamyl acetate (ISO), and 2,5-dimethyl pyrazine (2,5DP), at the indicated
concentrations. The inhibitors tested were verapamil at 200 mM (gray), cyclosporin A at 5 mM (black), probenecid at 2.5 mM, (light green) and MK571
at 25 mM (green). Note that for the mouse (in C) the results for 5 mM probenecid are shown. **p,0.001, * p,0.05.
doi:10.1371/journal.pone.0036167.g007
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Physiological modulation during ontogenesis can be hypothesized
for these proteins in OE similar to that during mouse and rat brain
maturation [44–46]. Our results corroborate the results obtained
with the functional assay. Both transporters have been fully
functional early at birth as the calcein-AM assay has been
performed on animals at the day of birth.
If Pgp and MRP transporters are functional in ORNs and in the
OE, would their presence contribute to the physiological activity of
ORNs, namely to the response to odorants? Comparison of the
EOGs and their kinetics provide valuable information about how
modifications or experimental manipulations influence the signal-
ing underlying the ORNs response to odorants. We analyzed
responses to single odorants and to an odorant mixture exciting a
large receptor population. We included two stimuli, KCl and
IBMX, which elicit EOGs not mediated by olfactory receptor
activation. The elevated KCl response is a measure of general OE
excitability, and IBMX, a phosphodiesterase inhibitor leads to an
increase in ciliary cAMP thus activating the downstream signal
transduction cascade.
Inactivation or reversal of Pgp and MRP function by
appropriate inhibitors was associated with a significant reduction
in EOG amplitude. Verapamil-mediated Pgp inhibition reduced
the amplitude of most odorant responses without significantly
affecting the amplitude of IBMX and KCl, indicating the
functioning of the cAMP signaling pathway. Based on this
observation one may hypothesize that Pgp may be interfering
directly with odorants or that interaction takes place at or close to
the olfactory receptor site. Other than as for Pgp dependant
interaction, the result can be interpreted by virtue of the quality of
verapamil as a blocker of voltage-activated calcium channels. The
localization of the cellular interaction of the transporters and/or
inhibitors with the odorant response can be inferred from the
EOG recordings. EOGs record generator potentials which arise
mostly in the ciliary parts of the ORNs where the signal
transduction process occurs. Contribution may also come from
the knob and the upper dendritic part of the ORN. As cilia do not
contain voltage-activated channels [47] the lipophilic verapamil
has to partition into the knob where L-type calcium channels are
localized [48]. They may open in response to odorants and be
closed by verapamil thus reducing the EOG amplitude. The Pgp
inhibitor cyclosporin only slightly reduced EOG amplitudes
indicating no significant interaction with odorant induced events.
This is in contrast to its strong inhibitory effect evidenced in the
calcein assay. There are two principle differences in the two
preparations which could account for this: e.g. the effect may
depend on the availability of the inhibitor at its target site. Other
than in the calcein assay where cells have been almost directly
exposed to the inhibitors, in the EOG experiments they have first
to travel across an aqueous layer of mucus to diffuse to their site of
action. Different physicochemical properties could influence their
passage. A more important difference is that not calcein-AM is the
substrate but an unknown Pgp-target molecule. There, inhibitory
effects may depend on the combination of transporter-substrate-
inhibitor and react differently in diverse assays. Although
cyclosporin and verapamil bind with high affinity to Pgp [49,50]
their interaction with Pgp differ [51,52]. It is also possible that the
anatomical localization of Pgp transporters is far from the site of
Figure 8. Comparison of the kinetics of olfactory responses during inhibitor application. Representative electroolfactogram (EOG) traces
from rat in response to the odorant mixture of 10
24 M before and during MDR inhibitor application. EOG traces were normalized to their maximum
amplitude and averaged for the comparison of their time course. Inhibitors applied were verapamil at 200 mM, CsA = cyclosporin A at 5 mM,
probenecid at 2.5 mM, and MK571 at 25 mM. Each averaged waveform represents the independent assessment from four different animals.
doi:10.1371/journal.pone.0036167.g008
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ical EOG recording. Regarding the discrepancies and the lack of
specific cyclosporin- and verapamil-mediated effects, it remains
unclear if the Pgp transporter is involved in the early part of the
olfactory response. To clarify this, further investigations are
needed.
Blockade of MRP function by probenecid or MK571 strongly
decreased and almost abolished EOG amplitudes of the odorant
and IBMX-induced responses. The fact that IMBX-induced
responses have also been reduced by MRP inhibitors suggests
that the interaction between MRP and/or inhibitors does not
occur at the receptor site. One has to consider whether any of the
inhibitors may have an effect on EOGs by interacting with one of
the elements in the signal transduction chain. Recently. Xie et al,
[53] demonstrated that MRP4 inactivation by MK571 and
probenecid is associated with reduced cAMP degradation by
cellular phosphodiesterases. According to their model, both MK
and probenecid acted as phosphodiesterase inhibitors in various
MRP4 expressing cell lines. MRP4 and MRP5 are transporters
associated with the efflux of cyclic nucleotides like cAMP and
cGMP from cells [54,55]. In ORNs, cAMP has a crucial role in
signal transduction and its level is tightly regulated by rapid
degradation of phosphodiesterases. Given that MK and proben-
ecid may block phosphodiesterases activity in ORNs this would be
similar to a functional ablation of their activity. This effect has
been studied in a mouse line with gene disruption for both
subtypes of phosphodiesterases identified in ORNs [56]. Contrary
to the assumption that the resulting increase in cAMP would lead
to an augmentation of the olfactory response, odorant-induced
EOGs exhibited significant reduced amplitudes. Also the unspe-
cific phosphodiesterase blocker IBMX reduced odorant–induced
current amplitudes in single ORNs when IBMX was applied
together with odorants [57]. Such mechanisms of action could
explain the reduced EOG amplitudes recorded in presence of MK
and probenecid. It is not known if the model of Xie et al. can be
extended to other MRPs than to MRP4, and which of the MRPs
in ORNs would participate in this process. Our calcein assay does
not provide information to which of the MRP isoforms is involved
in the fluorescence uptake. Possible contribution may come from
MRP1, MRP3, MRP4 or MRP5. While calcein is not a substrate
of MRP5, MRP5 activity may be inhibited by MK and
probenecid as shown for human MRP5 [58].
There is no simple interpreation to explain such changes in a
system where the measured response is the result of complex
pathways and feedback mechanisms. Reduced EOG amplitudes
are compatible with a faster response termination. The most
compatible explanation may be that MRP-like MDR transporters
interact with mechanisms in the calcium signaling network.
Calcium plays a pivotal role as a third messenger in olfactory
transduction and can either potentiate or attenuate the olfactory
signal [59]. Calcium can also modulate receptors and reduce
olfactory sensitivity [60].
Together, the data presented here have shown that MDR
transporters are functional in OE and in ORNs of rodents. They
also show how sensory responses to odorants were altered by
inactivation/inhibition of MDR function, especially by inhibition
of MRP-like transporters. Among proposed functional roles tissue
detoxification may be a vital element especially with the olfactory
epithelium being the principal site of absorption of inhaled
compounds. The interaction of natural and environmental
cytotoxic compounds with ABC transporter have been document-
ed in several studies [3,61]. Inhibition or inactivation of MDR
transporters may lead to reduced acuity and in turn modify animal
behavior. Besides being detrimental and health threatening to the
animal, it may also be beneficial as a continuous exposure may
induce up-regulation of the transporters in the olfactory tissue
[20]. There is also growing evidence of pheripheral modulation of
olfactory signals by input from autonomic innervations by
neurotransmitters [62]. MDRs may contribute to uptake and
efflux of such substances i.e. adrenaline which modulates signal
activities in the olfactory epithelium [63] may be transported by
MRP1 as shown for other tissue [64].
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